| ANIMAL | evidence | Traumatic brain injury in mice and pentadecapeptide BPC 157 effect. | BPC 157 | animal | 2010-02-25 |
| ANIMAL | evidence | Peptide therapy with pentadecapeptide BPC 157 in traumatic nerve injury. | BPC 157 | animal | 2010-02-25 |
| ANIMAL | evidence | Over-dose insulin and stable gastric pentadecapeptide BPC 157. Attenuated gastric ulcers, seizures, brain lesions, hepatomegaly, fatty liver, breakdown of liver glycogen, profound hypoglycemia and calcification in rats. | BPC 157 | animal | 2009-12-01 |
| ANIMAL | evidence | Antiinflammatory effect of BPC 157 on experimental periodontitis in rats. | BPC 157 | Inflammation · animal | 2009-12-01 |
| ANIMAL | evidence | Abdominal aorta anastomosis in rats and stable gastric pentadecapeptide BPC 157, prophylaxis and therapy. | BPC 157 | Muscle growth & preservation · animal | 2009-12-01 |
| ANIMAL | evidence | Gastric pentadecapeptide BPC 157 counteracts morphine-induced analgesia in mice. | BPC 157 | animal | 2009-12-01 |
| ANIMAL | evidence | Gastric pentadecapeptide BPC 157 and short bowel syndrome in rats. | BPC 157 | Gut barrier & GI healing · animal | 2009-10-01 |
| ANIMAL | evidence | Inhibition of methyldigoxin-induced arrhythmias by pentadecapeptide BPC 157: a relation with NO-system. | BPC 157 | Gut barrier & GI healing · animal | 2009-08-07 |
| ANIMAL | evidence | Therapy for unhealed gastrocutaneous fistulas in rats as a model for analogous healing of persistent skin wounds and persistent gastric ulcers: stable gastric pentadecapeptide BPC 157, atropine, ranitidine, and omeprazole. | BPC 157 | Gut barrier & GI healing · animal | 2009-01-01 |
| ANIMAL | evidence | Pentadecapeptide BPC 157, in clinical trials as a therapy for inflammatory bowel disease (PL14736), is effective in the healing of colocutaneous fistulas in rats: role of the nitric oxide-system. | BPC 157 | Gut barrier & GI healing · animal | 2008-09-01 |
| ANIMAL | evidence | Modulation of early functional recovery of Achilles tendon to bone unit after transection by BPC 157 and methylprednisolone. | BPC 157 | animal | 2008-05-01 |
| ANIMAL | evidence | Gastric pentadecapeptide BPC 157 as an effective therapy for muscle crush injury in the rat. | BPC 157 | Tendon & ligament repair · animal | 2008-01-01 |
| ANIMAL | evidence | Prolonged esophagitis after primary dysfunction of the pyloric sphincter in the rat and therapeutic potential of the gastric pentadecapeptide BPC 157. | BPC 157 | Gut barrier & GI healing · animal | 2007-05-01 |
| ANIMAL | evidence | Stable gastric pentadecapeptide BPC 157 in trials for inflammatory bowel disease (PL-10, PLD-116, PL14736, Pliva, Croatia) heals ileoileal anastomosis in the rat. | BPC 157 | Gut barrier & GI healing · animal | 2007-01-01 |
| ANIMAL | evidence | An experimental model of prolonged esophagitis with sphincter failure in the rat and the therapeutic potential of gastric pentadecapeptide BPC 157. | BPC 157 | Gut barrier & GI healing · animal | 2006-11-01 |
| ANIMAL | evidence | Achilles detachment in rat and stable gastric pentadecapeptide BPC 157: Promoted tendon-to-bone healing and opposed corticosteroid aggravation. | BPC 157 | Tendon & ligament repair · animal | 2006-05-01 |
| ANIMAL | evidence | Effective therapy of transected quadriceps muscle in rat: Gastric pentadecapeptide BPC 157. | BPC 157 | animal | 2006-05-01 |
| ANIMAL | evidence | The influence of gastric pentadecapeptide BPC 157 on acute and chronic ethanol administration in mice. The effect of N(G)-nitro-L-arginine methyl ester and L-arginine. | BPC 157 | Gut barrier & GI healing · animal | 2006-01-01 |
| ANIMAL | evidence | Accelerated healing of excisional skin wounds by PL 14736 in alloxan-hyperglycemic rats. | BPC 157 | animal | 2006-01-01 |
| ANIMAL | evidence | Gastric pentadecapeptide BPC 157 promotes corneal epithelial defects healing in rats. | BPC 157 | Gut barrier & GI healing · animal | 2005-06-01 |
| ANIMAL | evidence | The stable gastric pentadecapeptide BPC 157, given locally, improves CO2 laser healing in mice. | BPC 157 | Wound healing · animal | 2005-05-01 |
| ANIMAL | evidence | Gastric pentadecapeptide BPC 157 effective against serotonin syndrome in rats. | BPC 157 | animal | 2005-04-11 |
| ANIMAL | evidence | Effects of pentadecapeptide BPC157 on regional serotonin synthesis in the rat brain: alpha-methyl-L-tryptophan autoradiographic measurements. | BPC 157 | Gut barrier & GI healing · animal | 2004-12-03 |
| ANIMAL | evidence | The influence of gastric pentadecapeptide BPC 157 on acute and chronic ethanol administration in mice. | BPC 157 | Gut barrier & GI healing · animal | 2004-09-24 |
| ANIMAL | evidence | Doxorubicine-congestive heart failure-increased big endothelin-1 plasma concentration: reversal by amlodipine, losartan, and gastric pentadecapeptide BPC157 in rat and mouse. | BPC 157 | Lipid & cardiovascular markers · animal | 2004-05-01 |
| ANIMAL | evidence | Protective effects of pentadecapeptide BPC 157 on gastric ulcer in rats. | BPC 157 | Gut barrier & GI healing · animal | 2004-04-01 |
| ANIMAL | evidence | Gastric pentadecapeptide BPC 157 accelerates healing of transected rat Achilles tendon and in vitro stimulates tendocytes growth. | BPC 157 | Tendon & ligament repair · animal | 2003-11-01 |
| ANIMAL | evidence | Different effect of antiulcer agents on rat cysteamine-induced duodenal ulcer after sialoadenectomy, but not gastrectomy. | BPC 157 | Gut barrier & GI healing · animal | 2003-09-05 |
| ANIMAL | evidence | Corticosteroid-impairment of healing and gastric pentadecapeptide BPC-157 creams in burned mice. | BPC 157 | Wound healing · animal | 2003-06-01 |
| ANIMAL | evidence | Pentadecapeptide BPC 157 attenuates chronic amphetamine-induced behavior disturbances. | BPC 157 | animal | 2002-05-01 |
| ANIMAL | evidence | Pentadecapeptide BPC 157 cream improves burn-wound healing and attenuates burn-gastric lesions in mice. | BPC 157 | Wound healing · animal | 2001-12-01 |
| ANIMAL | evidence | Haloperidol-stomach lesions attenuation by pentadecapeptide BPC 157, omeprazole, bromocriptine, but not atropine, lansoprazole, pantoprazole, ranitidine, cimetidine and misoprostol in mice. | BPC 157 | Gut barrier & GI healing · animal | 2001-03-09 |
| ANIMAL | evidence | Anxiolytic effect of BPC-157, a gastric pentadecapeptide: shock probe/burying test and light/dark test. | BPC 157 | Mood & anxiety · animal | 2001-03-01 |
| ANIMAL | evidence | Lung lesions and anti-ulcer agents beneficial effect: anti-ulcer agents pentadecapeptide BPC 157, ranitidine, omeprazole and atropine ameliorate lung lesion in rats. | BPC 157 | Gut barrier & GI healing · animal | 2001-01-01 |
| ANIMAL | evidence | Chronic cytoprotection: pentadecapeptide BPC 157, ranitidine and propranolol prevent, attenuate and reverse the gastric lesions appearance in chronic alcohol drinking rats. | BPC 157 | Gut barrier & GI healing · animal | 2001-01-01 |
| ANIMAL | evidence | Ethanol gastric lesion aggravated by lung injury in rat. Therapy effect of antiulcer agents. | BPC 157 | Gut barrier & GI healing · animal | 2001-01-01 |
| ANIMAL | evidence | Therapy effect of antiulcer agents on new chronic cysteamine colon lesion in rat. | BPC 157 | Gut barrier & GI healing · animal | 2001-01-01 |
| ANIMAL | evidence | Cysteamine-colon and cysteamine-duodenum lesions in rats. Attenuation by gastric pentadecapeptide BPC 157, cimetidine, ranitidine, atropine, omeprazole, sulphasalazine and methylprednisolone. | BPC 157 | Gut barrier & GI healing · animal | 2001-01-01 |
| ANIMAL | evidence | Portal hypertension and liver lesions in chronically alcohol drinking rats prevented and reversed by stable gastric pentadecapeptide BPC 157 (PL-10, PLD-116), and propranolol, but not ranitidine. | BPC 157 | Addiction & substance use · animal | 2001-01-01 |
| ANIMAL | evidence | Gastric mucosal lesions induced by complete dopamine system failure in rats. The effects of dopamine agents, ranitidine, atropine, omeprazole and pentadecapeptide BPC 157. | BPC 157 | Gut barrier & GI healing · animal | 2000-03-01 |
| ANIMAL | evidence | The antidepressant effect of an antiulcer pentadecapeptide BPC 157 in Porsolt's test and chronic unpredictable stress in rats. A comparison with antidepressants. | BPC 157 | Mood & anxiety · animal | 2000-03-01 |
| ANIMAL | evidence | Long-lasting cytoprotection after pentadecapeptide BPC 157, ranitidine, sucralfate or cholestyramine application in reflux oesophagitis in rats. | BPC 157 | Gut barrier & GI healing · animal | 1999-12-01 |
| ANIMAL | evidence | Pentadecapeptide BPC 157 attenuates gastric lesions induced by alloxan in rats and mice. | BPC 157 | Gut barrier & GI healing · animal | 1999-12-01 |
| ANIMAL | evidence | The effect of pentadecapeptide BPC 157, H2-blockers, omeprazole and sucralfate on new vessels and new granulation tissue formation. | BPC 157 | Gut barrier & GI healing · animal | 1999-12-01 |
| ANIMAL | evidence | A behavioural study of the effect of pentadecapeptide BPC 157 in Parkinson's disease models in mice and gastric lesions induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydrophyridine. | BPC 157 | Gut barrier & GI healing · animal | 1999-12-01 |
| ANIMAL | evidence | The effect of a novel pentadecapeptide BPC 157 on development of tolerance and physical dependence following repeated administration of diazepam. | BPC 157 | Gut barrier & GI healing · animal | 1999-09-30 |
| ANIMAL | evidence | Pentadecapeptide BPC 157 attenuates disturbances induced by neuroleptics: the effect on catalepsy and gastric ulcers in mice and rats. | BPC 157 | Gut barrier & GI healing · animal | 1999-08-20 |
| ANIMAL | evidence | Osteogenic effect of a gastric pentadecapeptide, BPC-157, on the healing of segmental bone defect in rabbits: a comparison with bone marrow and autologous cortical bone implantation. | BPC 157 | animal | 1999-03-01 |
| ANIMAL | evidence | New model of cytoprotection/adaptive cytoprotection in rats: endogenous small irritants, antiulcer agents and indomethacin. | BPC 157 | Gut barrier & GI healing · animal | 1999-01-01 |
| ANIMAL | evidence | A novel pentadecapeptide, BPC 157, blocks the stereotypy produced acutely by amphetamine and the development of haloperidol-induced supersensitivity to amphetamine. | BPC 157 | Gut barrier & GI healing · animal | 1998-04-01 |